Polycystic ovary syndrome and cardiovascular risk: asking the right questions-Reference-Cited by-同舟云学术

Polycystic ovary syndrome and cardiovascular risk: asking the right questions

Published:2024-05-09 Issue: Volume: Page:
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Safwan Nancy¹²,Saadedine Mariam¹²,Bairey Merz C Noel³^ORCID,Shufelt Chrisandra L¹²⁴

Affiliation:

1. Division of General Internal Medicine, Mayo Clinic , Jacksonville, FL , USA

2. Department of Internal Medicine, Mayo Clinic Center for Women’s Health , Rochester, MN , USA

3. Barbra Streisand Women’s Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center , 127 S. San Vicente 90248, Los Angeles, CA , USA

4. Women’s Health Research Center, Mayo Clinic , Rochester, MN , USA

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwae159/57693343/zwae159.pdf

Reference10 articles.

1. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett;Circulation,2019

2. Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome;Wan;Eur J Prev Cardiol,2024

3. Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis;Lo;Eur Heart J Open,2023

4. Polycystic ovary syndrome (PCOS) transition at menopause;Shah;J Midlife Health,2021

5. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis;Ramezani Tehrani;Gynecol Endocrinol,2020